Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Phone972-390-9800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$152.45 million
Profitability
Miscellaneous
Employees570
Next Earnings Date11/8/2019 (Estimated)
OptionableNot Optionable
Atrion (NASDAQ:ATRI) Frequently Asked Questions
What is Atrion's stock symbol?
Atrion trades on the NASDAQ under the ticker symbol "ATRI."
How often does Atrion pay dividends? What is the dividend yield for Atrion?
Atrion declared a quarterly dividend on Monday, August 19th. Shareholders of record on Monday, September 16th will be given a dividend of $1.55 per share on Monday, September 30th. This represents a $6.20 annualized dividend and a yield of 0.80%. The ex-dividend date of this dividend is Friday, September 13th. This is a boost from Atrion's previous quarterly dividend of $1.35. View Atrion's Dividend History.
How were Atrion's earnings last quarter?
Atrion Co. (NASDAQ:ATRI) announced its earnings results on Wednesday, August, 7th. The medical instruments supplier reported $5.18 earnings per share (EPS) for the quarter. The medical instruments supplier had revenue of $40.10 million for the quarter. Atrion had a net margin of 23.14% and a return on equity of 16.79%. View Atrion's Earnings History.
When is Atrion's next earnings date?
Has Atrion been receiving favorable news coverage?
News stories about ATRI stock have trended positive this week, InfoTrie reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Atrion earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future. View News Stories for Atrion.
Are investors shorting Atrion?
Atrion saw a increase in short interest in July. As of July 31st, there was short interest totalling 104,500 shares, an increase of 31.0% from the June 30th total of 79,800 shares. Based on an average trading volume of 14,300 shares, the short-interest ratio is currently 7.3 days. Currently, 7.4% of the company's stock are short sold. View Atrion's Current Options Chain.
Who are some of Atrion's key competitors?
Some companies that are related to Atrion include Integra Lifesciences (IART), Penumbra (PEN), Globus Medical (GMED), Cantel Medical (CMD), Tandem Diabetes Care (TNDM), NuVasive (NUVA), ICU Medical (ICUI), Nevro (NVRO), Glaukos (GKOS), Merit Medical Systems (MMSI), Irhythm Technologies (IRTC), Cardiovascular Systems (CSII), Silk Road Medical (SILK), Shockwave Medical (SWAV) and AtriCure (ATRC).
What other stocks do shareholders of Atrion own?
Who are Atrion's key executives?
Atrion's management team includes the folowing people:
- Mr. Emile A. Battat, Exec. Chairman (Age 81)
- Mr. David A. Battat, Pres & CEO (Age 49)
- Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60)
Who are Atrion's major shareholders?
Atrion's stock is owned by a number of of retail and institutional investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (10.06%), Price T Rowe Associates Inc. MD (8.88%), BlackRock Inc. (5.42%), Vanguard Group Inc. (4.76%), Renaissance Technologies LLC (3.28%) and Atria Investments LLC (1.33%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion.
Which major investors are selling Atrion stock?
ATRI stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Bessemer Group Inc., Bank of New York Mellon Corp, Schroder Investment Management Group, Schroder Investment Management Group, THB Asset Management, Morgan Stanley and Zebra Capital Management LLC. Company insiders that have sold Atrion company stock in the last year include Jeffery Strickland and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion.
Which major investors are buying Atrion stock?
ATRI stock was bought by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Atria Investments LLC, Nuveen Asset Management LLC, Marshall Wace LLP, Vanguard Group Inc., First Trust Advisors LP, Invesco Ltd. and JPMorgan Chase & Co.. View Insider Buying and Selling for Atrion.
How do I buy shares of Atrion?
Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Atrion's stock price today?
One share of ATRI stock can currently be purchased for approximately $778.60.
How big of a company is Atrion?
What is Atrion's official website?
How can I contact Atrion?
Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]
MarketBeat Community Rating for Atrion (NASDAQ ATRI)
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
